Spatial epidemiology of recently acquired HIV infections across rural and urban areas of North Carolina

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Carrel, Margaret ^a   Eron Jr , Joseph J ^b   Emch, Michael ^c   Hurt, Christopher B ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; FEMALE; GENETIC DIFFERENCE; GENETIC DISTANCE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; NUCLEOTIDE SEQUENCE; PHYLOGENY; RURAL AREA; UNITED STATES; URBAN AREA; VIRUS STRAIN; VIRUS TRANSMISSION;

ADULT; AFRICAN AMERICANS; DEMOGRAPHY; DRUG RESISTANCE, VIRAL; FEMALE; GENETIC VARIATION; GEOGRAPHY; HEALTH SERVICES; HETEROSEXUALITY; HIV INFECTIONS; HUMANS; MALE; NORTH CAROLINA; RISK FACTORS; RURAL POPULATION; SEXUAL BEHAVIOR; URBAN POPULATION; YOUNG ADULT;

EID: 84895768146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088512     Document Type: Article

References (36)

1. Centers for Disease Control (CDC) (2013) HIV surveillance report, 2011.
2. Southern HIV/AIDS Strategy Initiative (2012) SASI update: The continuing HIV crisis in the US south.
3. Aral SO, O'Leary A, Baker C (2006) Sexually transmitted infections and HIV in the southern united states: An overview. Sex Transm Dis 33(7): S1-S5. (Pubitemid 43964737)
4. Gant Z, Lomotey M, Hall H, Hu X, Guo X, et al. (2012) A county-level examination of the relationship between HIV and social determinants of health: 40 states, 2006-2008. The Open AIDS Journal 6: 1.
5. Lieb S, Prejean J, Thompson DR, Fallon SJ, Cooper H, et al. (2011) HIV prevalence rates among men who have sex with men in the southern united states: Population-based estimates by race/ethnicity. AIDS and Behavior 15(3): 596-606.
6. Prejean J, Song R, Hernandez A, Ziebell R, Green T, et al. (2011) Estimated HIV incidence in the united states, 2006-2009. PloS One 6(8): e17502.
7. Harrison KMD, Song R, Zhang X (2010) Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, united states. JAIDS J Acquired Immune Defic Syndromes 53(1): 124.
8. Collaboration HIVC, Ray M, Logan R, Sterne J, Hernandez-Diaz S, et al. (2010) The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS 24(1): 123.
9. Boden D, Hurley A, Zhang L, Cao Y, Guo Y, et al. (1999) HIV-1 drug resistance in newly infected individuals. JAMA: The Journal of the American Medical Association 282(12): 1135-1141. (Pubitemid 29441957)
10. Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, et al. (2009) Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PloS One 4(3): e4724.
11. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, et al. (2002) Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347(6): 385-394. (Pubitemid 34851830)
12. Panel on Antiretroviral Guidelines for Adults and Adolescents (2013) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services : 1-128.
13. Soeters HM, Napravnik S, Zakharova OM, Eron JJ, Hurt CB. (2013) Opportunities for sexual transmission of antiretroviral drug resistance among HIV-infected patients in care. AIDS 27: 000-000.
14. Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, et al. (2002) Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA: The Journal of the American Medical Association 288(2): 181-188. (Pubitemid 34755278)
15. Weinstock HS, Zaidi I, Heneine W, Bennett D, Garcia-Lerma GJ, et al. (2004) The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. J Infect Dis 189(12): 2174-2180. (Pubitemid 38757188)
16. Ross L, Lim ML, Liao Q, Wine B, Rodriguez AE, et al. (2007) Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 united states cities. HIV Clinical Trials 8(1): 1-8. (Pubitemid 46542904)
17. Hurt CB, McCoy SI, Kuruc J, Nelson J, Kerkau M, et al. (2009) Transmitted antiretroviral drug resistance among acute and recent HIV infections in north carolina, 1998 to 2007. Antivir Ther (Lond) 14(5): 673.
18. Cane P, Chrystie I, Dunn D, Evans B, Geretti A, et al. (2005) Time trends in primary resistance to HIV drugs in the united kingdom: Multicentre observational study. BMJ 331(7529): 1368-1368.
19. Masquelier B, Bhaskaran K, Pillay D, Gifford R, Balestre E, et al. (2005) Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: Data from seroconverters in the CASCADE collaboration from 1987 to 2003. JAIDS J Acquired Immune Defic Syndromes 40(5): 505-511. (Pubitemid 41669152)
20. Wensing AM, van de Vijver, DA, Angarano G, Åsjö B, Balotta C, et al. (2005) Prevalence of drug-resistant HIV-1 variants in untreated individuals in europe: Implications for clinical management. J Infect Dis 192(6): 958-966. (Pubitemid 41266791)
21. Vercauteren J, Wensing AM, van de Vijver, David AMC, Albert J, et al. (2009) Transmission of drug-resistant HIV-1 is stabilizing in europe. J Infect Dis 200(10): 1503-1508.
22. Yanik EL, Napravnik S, Hurt CB, Dennis A, Quinlivan EB, et al. (2012) Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients. JAIDS J Acquired Immune Defic Syndromes 61(2): 258-262.
23. Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, et al. (2012) Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: A global collaborative study and meta-regression analysis. The Lancet.
24. Dennis AM, Hué S, Hurt CB, Napravnik S, Sebastian J, et al. (2012) Phylogenetic insights into regional HIV transmission. AIDS 26(14): 1813-1822.
25. Oster AM, Pieniazek D, Zhang X, Switzer WM, Ziebell RA, et al. (2011) Demographic but not geographic insularity in HIV transmission among young black MSM. AIDS 25(17): 2157-2165.
26. Hurt CB, Dennis AM (2013) Putting it all together: Lessons from the jackson HIV outbreak investigation. Sex Transm Dis 40(3): 213-215.
27. McKellar MS, Cope AB, Gay CL, McGee KS, Kuruc JD, et al. (2013) Acute HIV-1 infection in the southeastern united states: A cohort study. AIDS Res Hum Retroviruses 29(1): 121-128.
28. Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, et al. (2001) HIV in body fluids during primary HIV infection: Implications for pathogenesis, treatment and public health. AIDS 15(7): 837-845. (Pubitemid 32424387)
29. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, et al. (2005) Detection of acute infections during HIV testing in north carolina. N Engl J Med 352(18): 1873-1883. (Pubitemid 40627813)
30. Pilcher CD, McPherson JT, Leone PA, Smurzynski M, Owen-O'Dowd J, et al. (2002) Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA: The Journal of the American Medical Association 288(2): 216-221. (Pubitemid 34755282)
31. Cohen MS, Shaw GM, McMichael AJ, Haynes BF (2011) Acute HIV-1 infection. N Engl J Med 364(20): 1943-1954.
32. Edgar RC (2004) MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32(5): 1792-1797.
33. Stamatakis A (2006) RAxML-VI-HPC: Maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22(21): 2688-2690.
34. Fourment M, Gibbs M (2006) PATRISTIC: A program for calculating patristic distances and graphically comparing the components of genetic change. BMC Evolutionary Biology 6(1): 1.
35. Prejean J, Tang T, Hall HI (2012) HIV diagnoses and prevalence in the southern region of the united states, 2007-2010. J Community Health : 1-13.
36. Dennis AM, Napravnik S, Seña AC, Eron JJ (2011) Late entry to HIV care among latinos compared with non-latinos in a southeastern US cohort. Clinical Infectious Diseases 53(5): 480-487.